GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuyu Pharma Inc (XKRX:000220) » Definitions » Other Income (Expense)

Yuyu Pharma (XKRX:000220) Other Income (Expense) : ₩-4,150 Mil (TTM As of Dec. 2023)


View and export this data going back to 1975. Start your Free Trial

What is Yuyu Pharma Other Income (Expense)?

Yuyu Pharma's other income expense for the Yuyu Pharma's pretax income for the three months ended in Dec. 2023 was ₩-1,379 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-4,150 Mil.


Yuyu Pharma Other Income (Expense) Historical Data

The historical data trend for Yuyu Pharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuyu Pharma Other Income (Expense) Chart

Yuyu Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.24 -966.99 391.07 -1,200.74 -4,149.64

Yuyu Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,240.90 -979.43 -1,543.03 -248.59 -1,378.59

Yuyu Pharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-4,150 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yuyu Pharma  (XKRX:000220) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Yuyu Pharma (XKRX:000220) Business Description

Traded in Other Exchanges
Address
197, Dongho-ro, Yuyu Building, Jung-gu, Seoul, KOR
Yuyu Pharma Inc. manufactures and markets medicines. The major product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Yuyu Pharma (XKRX:000220) Headlines

No Headlines